跳至主要内容
临床试验/NL-OMON24816
NL-OMON24816招募中不适用

A prospective Randomized Controlled Trial to Evaluate the Prevention of sudden cardiac death using implantable cardioverter defibrillators in dialysis patients.

eids University Medical Center (LUMC)0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients 55 to 80 years of age;
  • 2. End Stage Renal Disease (ESRD);
  • 3. > 90 days after start dialysis.

排除标准

  • 1. Possible living kidney donation;
  • 2. Terminal congestive heart failure according NYHA class 4 at time of randomization;
  • 3. Non arrhythmic medical condition making 1-year survival unlikely;
  • 4. Excessive perioperative risk for ICD implantation;
  • 5. HIV infection;
  • 6. Patients with central venous line;
  • 7. Acute Myocardial Infarction (AMI) last 40 days;
  • 8. ICD indication according current guidelines;
  • 9. Expected poor compliance with protocol.

研究者

发起方
eids University Medical Center (LUMC)

相似试验